Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies

Rachel Sacks‐Davis(Burnet Institute), Coralie Khan, Laurence Merchadou, Tim Spelman(Peter Doherty Institute), Philippe Sogni(Hôpital Saint-Vincent-de-Paul), Margaret Hellard(The Alfred Hospital), Dominique Salmon‐Céron(Délégation Paris 5), Maria-Bernarda Requena(Inserm), Anders Boyd, Marina B. Klein(Royal Victoria Regional Health Centre), Tianhui Ke(University of Melbourne), Jim Young(McGill University), Catrina Mugglin(University of Bern), Colette Smit(Stichting HIV Monitoring), Inmaculada Jarrín(Instituto de Salud Carlos III), Laure Esterle, Joseph Doyle(The Alfred Hospital), S. Gillet, Camille Gilbert, Dominique Salmon(Assistance Publique – Hôpitaux de Paris), Ashleigh Stewart(Burnet Institute), Gail Matthews(UNSW Sydney), Rebecca Guy(New South Wales Institute of Psychiatry), Janke Schinkel(Amsterdam UMC Location University of Amsterdam), Daniela K van Santen(Burnet Institute), Fabrice Bonnet(Centre Hospitalier Universitaire de Bordeaux), Jason Asselin(Burnet Institute), Karine Lacombe(Inserm), Joshua Dawe, Alisa Pedrana(Burnet Institute), Mark Stoové(Monash University), Anna L. Wilkinson(Burnet Institute), Yanqin Zhang, Marc van der Valk(Academic Medical Center), Linda Wittkop(Université de Bordeaux), Colette Smit(Stichting HIV Monitoring), Natasha K. Martin(University of California San Diego)
The Lancet HIV
January 21, 2024
Cited by 24


Related Papers